Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
ARK.V 0SGD.V 0.46AEM.TO -4.78MEQ.TO -1.05TRI.TO 2.93KKR 1.49CGI.TO -0.09KINS -0.06
Daily Stock Opinions and Ratings
The ultimate 360° Tracker Your financial life in one place, automatically
Stockchase Opinions

Larry Berman CFA, CMT, CTAPanGeo PharmaPIL.H.VDON'T BUYSep 03, 2002

In a downtrend.
Larry Berman CFA, CMT, CTALarry Berman CFA, CMT, CTA
Unknown
Unlock Rating
$2.48

Stock price when the opinion was issued

biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
Get Signals Create your Watchlist

You might be interested:

DON'T BUY

PanGeo Pharma(PIL.H.V)

Sep 22, 2003
Trading has been stopped. Plagued by a number of problems. Waiting for the company to complete its audit.
Photo of Robert FloydRobert Floyd
Owned
Unlock Rating
$0.29

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

PanGeo Pharma(PIL.H.V)

Jul 22, 2003
Doesn't look good.
Photo of David BurrowsDavid Burrows
No
Unlock Rating
$0.29

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

PanGeo Pharma(PIL.H.V)

Jul 04, 2003
Auditors left and have to be replaced and trading has been stopped until their reports are in.
Photo of Robert FloydRobert Floyd
Owned
Unlock Rating
$0.29

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

PanGeo Pharma(PIL.H.V)

Jul 02, 2003
In a very defined downtrend.
Photo of Bill CarriganBill Carrigan
No
Unlock Rating
$0.29

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

PanGeo Pharma(PIL.H.V)

May 30, 2003
Very extended. Squeezing their credit lines and suppliers. Have to earn $0.10 a share to support the liquidity issue.
Photo of Lou SchizasLou SchizasUnlock Rating
$0.74

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

PanGeo Pharma(PIL.H.V)

May 06, 2003
Have had some pretty big earnings misses and management issues. May be a take over target at some point. Wait for it to drop further.
Photo of Peter HodsonPeter HodsonUnlock Rating
$0.96

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

PanGeo Pharma(PIL.H.V)

Apr 25, 2003
Made a good move in splitting the offices of the chairman and the CEO. They are trying to deal with their problems. Have to see an improvement before there is any interest.
Photo of Robert FloydRobert FloydUnlock Rating
$0.76

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

PanGeo Pharma(PIL.H.V)

Apr 10, 2003
Has warned a few times. Making some strategic moves in beefing up their management. A reasonable bet.
Photo of Robert FloydRobert FloydUnlock Rating
$0.77

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

PanGeo Pharma(PIL.H.V)

Mar 31, 2003
Likes this sector, but they just gave a lower guidance.
Photo of John Sinkins, CFAJohn Sinkins, CFAUnlock Rating
$0.69

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

PanGeo Pharma(PIL.H.V)

Mar 27, 2003
Earnings warnings were forcast. Seems to be corrected now. Cheap.
Photo of Robert FloydRobert FloydUnlock Rating
$0.73

Stock price when the opinion was issued

biotechnologypharmaceutical
HOLD

PanGeo Pharma(PIL.H.V)

Mar 03, 2003
Making some management changes which will take time.
Photo of Robert FloydRobert FloydUnlock Rating
$0.83

Stock price when the opinion was issued

biotechnologypharmaceutical
PAST TOP PICK

PanGeo Pharma(PIL.H.V)

Feb 07, 2003
(Was a top pick on Dec 18.Down 55%.) Stock was knocked down, but problems are being looked after.
Photo of Robert FloydRobert FloydUnlock Rating
$0.92

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

PanGeo Pharma(PIL.H.V)

Feb 04, 2003
Way off on their earnings guidance. Will take a while to recover.
Photo of Peter HodsonPeter HodsonUnlock Rating
$1.01

Stock price when the opinion was issued

biotechnologypharmaceutical
WEAK BUY

PanGeo Pharma(PIL.H.V)

Feb 03, 2003
Could go up. Has been oversold. Treat as a trade.
Photo of Michael SmedleyMichael SmedleyUnlock Rating
$1.11

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

PanGeo Pharma(PIL.H.V)

Jan 31, 2003
Has missed for the 3rd time. Prefers others.
Photo of Andrew McCreathAndrew McCreathUnlock Rating
$0.93

Stock price when the opinion was issued

biotechnologypharmaceutical

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

BTE.TO 0.11$5.71
CS.TO -0.62$14.61
SKE.TO -0.73$39.75
WHN.V 0$0.29
SII.TO -7.01$165.77

Today's Top Picks

ARK.V 0$
SGD.V 0.46$15.93
AEM.TO -4.78$231.28
MEQ.TO -1.05$168.2
TRI.TO 2.93$113.95

Popular Articles

Latest Sell Signals

DOL.TO -0.96$186.89
CTC.A.TO -0.55$186.09
CCO.TO 0.61$151.07
CAT 1.18$987
EQB.TO 1.5$126.19

Most Recent Experts

Rick Rule

Rick Rule

Rule Investment Media

Chris Blumas

Chris Blumas

at Raymond James Investment Counsel Ltd.

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica